This review focuses on the federal fraud and abuse, conflict of interest and medical ethics concerns associated with physician-owned distributor entities (hereinafter PODs) in the medical device products industry and provides a compelling rationale for stakeholders to avoid doing business with these entities, particularly in light of recent Office of Inspector General (OIG) fraud and abuse guidance on the anti-kickback implications of these proliferating arrangements.